posted on 2021-01-14, 17:04authored byJie Sun, Shanying Han, Leyao Ma, Hao Zhang, Zhen Zhan, Hillary Andaluz Aguilar, Haiyang Zhang, Ke Xiao, Yanhong Gu, Zhongze Gu, W. Andy Tao
Extracellular vesicles (EVs) have
emerged as important carriers
for intercellular communication and biological sources for diagnosis
and therapeutics. Low efficiency in EV isolation from biofluids, however,
severely restricts their downstream characterization and analysis.
Here, we introduced a novel strategy for EV isolation from urine for
prostate cancer diagnosis using bifunctionalized magnetic beads through
high affinity Ti(IV) ions and the insertion of a phospholipid derivative,
1,2-distearoyl-<i>sn</i>-glycero-3-phosphoethanolamine,
into the EV membrane synergistically. We demonstrated its efficient
isolation of EVs from urine samples with low contamination, high recovery
(>80%), and short separation time (within 1 h), resulting in the
identification
of 36,262 unique EV peptides corresponding to 3302 unique proteins
and 3233 unique phosphopeptides representing 1098 unique phosphoproteins
using only 100 μL and 5 mL urine samples, respectively. Coupled
with trapped ion mobility spectrometry and parallel accumulation–serial
fragmentation for phosphosite-specific resolution, quantitative phosphoproteomics
of urine samples from prostate cancer patients and healthy individuals
revealed 121 upregulated phosphoproteins in cancer patients in contrast
to the healthy group. These particular advantages indicate that the
novel bifunctional material enables sensitive EV phosphoproteomic
analysis for noninvasive biomarker screening and early cancer diagnosis.